“A very strong commercial thought partner, a strong negotiator, and truly understands clients’ businesses”

The Legal 500 US 2019

Shaun D. Hartley

  • 330 North Wabash Avenue, Suite 2800
  • Chicago, IL 60611
  • USA

Shaun Hartley is the Co-Chair of the Chicago Corporate Department and the former Global Co-Chair of the firm’s Private Equity Practice. He advises private equity firms and their portfolio companies on mergers and acquisitions, including The Carlyle Group, Onex Partners, Novolex, Loc Performance, and Two Six Technologies.

Mr. Hartley works on a variety of M&A transactions, including leveraged acquisitions, divestitures of business divisions, going-private transactions, and other strategic acquisitions and dispositions, in the following industries: manufacturing, consumer products, hospitality, automotive, healthcare, and technology, among others. His practice also includes joint ventures and general company representation matters.

Mr. Hartley’s experience includes advising:

  •  The Carlyle Group
    • Acquisition from CBAM Partners, an affiliate of Eldridge, of a portfolio of assets under management using a combination of US$615 million in cash and approx. 4.2 million newly issued common shares

    • Sale by Carlyle of a majority stake in Novolex, a leading global manufacturer of diverse packaging products for the foodservice, delivery and carryout, food processor and industrial markets, to Apollo

    • Acquisition of CNSI, a leading healthcare technology solutions provider, from Alvarez & Marsal Capital Partners

    • Sale by Carlyle of Novetta, an advanced analytics company serving US federal organizations, to Accenture Federal Services, a wholly owned subsidiary of Accenture (NYSE: ACN)

    • US$230 million acquisition of Signature Aviation’s Engine Repair and Overhaul (ERO) business by StandardAero, a provider of Maintenance, Repair and Overhaul (MRO) services and a portfolio company of The Carlyle Group

    • Acquisition of IST Research and Two Six Labs, which have combined to form Two Six Technologies, Inc., a technology-focused provider to the Intelligence Community, Department of Defense, and other critical US national security customers, and the subsequent add-on acquisitions of Trusted Concepts Inc., River Loop Security, and Thresher Ventures

    • Formation of CorroHealth through the combination of TrustHCS, Visionary RCM, T-System, and RevCycle+ and the subsequent add-on acquisitions of Versalus Health, TCP Services and Analytics, Medical Savant, ParaRev, and Aergo Solutions

    • Acquisition of a majority stake in Victory Innovations, a manufacturer of cordless electrostatic sprayers used to disinfect offices, airplanes, schools, and other businesses

    • Sale of Sundyne by BC Partners and Carlyle to Warburg Pincus

    • US$1.45 billion sale of Precision Flow Systems by BC Partners and Carlyle to Ingersoll-Rand plc (NYSE: IR)

    • Acquisition of Apollo Aviation Group, a global commercial aviation investment and servicing firm with US$5.6 billion in assets under management, including 243 aircraft owned, managed, or committed to purchase, which will become a new business line within Carlyle’s Global Credit Segment

    • US$2.3 billion acquisition of The Waddington Group from Newell Brands, Inc. by Novolex Holdings, LLC, a Carlyle portfolio company

    • Sale of majority control of The Nature’s Bounty Co., a global manufacturer, marketer, and distributor of health and wellness products, to KKR

    • US$1.245 billion sale of the Sullair compressor business by Accudyne Industries, a portfolio company of BC Partners and Carlyle, to Hitachi, Ltd.

    • Acquisition by Carlyle of Novolex™, a world leader in packaging choice and sustainability, from Wind Point Partners and TPG Growth, and the add-on acquisition of the Shields Bag & Printing business

    • US$3.3 billion sale of OGX shampoo maker Vogue International LLC to Johnson & Johnson (NYSE: JNJ)

    • US$2.07 billion sale of Landmark Aviation, an operator of a global network of fixed-base operations (FBOs), aircraft maintenance, and aircraft management and charter businesses, to BBA Aviation plc (LSE: BBA)

    • Acquisition by Carlyle of Novetta Solutions, a software and IT services provider, from Arlington Capital Partners

    • Acquisition by Carlyle of Acosta Sales & Marketing, a sales and marketing agency serving consumer packaged goods companies and retailers across the United States and Canada, from Thomas H. Lee Partners

    • Sale by Carlyle of its stake in PQ Corporation, a producer of specialty inorganic performance chemicals, high-end catalysts, and engineered glass beads, to CCMP Capital and INEOS

    • US$3.46 billion leveraged acquisition by Carlyle and BC Partners of the Milton Roy, Sullair, and Sundyne industrial products businesses (now known as Accudyne Industries) from United Technologies Corporation

    • Sale of the Sequa Automotive Group, comprising ARC Automotive (a manufacturer of airbag inflators) and CASCO Products (a manufacturer of power outlets, sensors, and other automotive components), to private equity firm The Jordan Company

    • US$5.6 billion leveraged acquisition by Carlyle and Onex Partners of the Allison Transmission Division of General Motors Corporation, which manufactures automatic transmissions and hybrid propulsion systems for commercial and military vehicles, and the subsequent initial public offering of Allison Transmission, Inc. (NYSE: ALSN)

    • US$3.9 billion leveraged buyout of Pharmaceutical Product Development, Inc. (NASDAQ: PPD) by Carlyle and Hellman & Friedman Capital Partners

    • Acquisition by Carlyle of Philosophy, a privately held manufacturer of cosmetics and personal care products, and the subsequent sale of Philosophy to Coty, Inc., a global beauty and fragrance company

    • Investment by Carlyle in the US$22 billion leveraged buyout of Kinder Morgan, Inc., an energy transportation, storage, and distribution company

    • Sale by Carlyle of Empi, Inc., a manufacturer of non-invasive medical products for physical rehabilitation, to Encore Medical Corporation 

  • Onex Partners

    • Investment by Onex in Analytic Partners, a leading cloud-based, managed software platform that helps global F1000 customers assess marketing spend effectiveness and optimize future allocations across offline and online media channels
    • Investment by Onex in Resource Environmental Solutions, a company supporting the public and private sectors with solutions for environmental mitigation, stormwater, water quality, and climate and flooding resilience
    • Acquisition of Fidelity Building Services Group, in partnership with the company’s management team
    • Acquisition by Onex of Newport Healthcare, a provider of behavioral healthcare services for teens, young adults, and their families, from Carlyle
    • Investment by Onex in Weld North Education, a US K-12 digital curriculum company, in partnership with the company’s management team and existing investor, Silver Lake

    • Acquisition by Onex of SMG, a provider of entertainment and conference venue management services worldwide, from Northlane Capital Partners

    • US$3.55 billion acquisition by Onex and Baring Private Equity Asia of the Intellectual Property & Science business (renamed Clarivate Analytics) from Thomson Reuters Corporation, and the subsequent public listing of Clarivate Analytics on the New York Stock Exchange through a transaction with Churchill Capital Corp (NYSE: CCC), a public special purpose investment vehicle, with an implied enterprise value of approximately US$4.2 billion

    • US$5.4 billion sale of Gates Corporation to Blackstone Group by Onex and Canadian Pension Plan Investment Board       

  • The Pritzker Organization — US$1 billion leveraged buyout of TMS International Corp. (NYSE: TMS) by certain Pritzker family business interests

  • Koch Industries

    • US$240 million non-voting preferred stock investment by Koch Industries in the Weiss family’s take-private of American Greetings Corporation (NYSE: AM)

    • US$300 million sale by Koch Industries of its asphalt products division to SemGroup

  • Royal DSM

    • Acquisition of MixFit Inc., a personalized nutrition solution company based in Boston

    • US$2.6 billion transaction involving a joint venture with JLL Partners to acquire Patheon Inc. in a take private transaction and combine with DSM Pharmaceutical Products to form a global contract development and manufacturing organization for the pharmaceutical industry, and the subsequent initial public offering of Patheon N.V. (NYSE: PTHN)

    • US$50 million preferred equity investment in Amyris, Inc. (NASDAQ: AMRS), the industrial bioscience company, and DSM’s subsequent M&A and other financing transactions involving Amyris

    • Acquisition of a controlling interest in Japan Fine Coatings Co. Ltd. from joint venture partner, JSR Corporation

  • GTCR — Equity financing for Zayo Group, LLC's US$2.2 billion acquisition of AboveNet, Inc. (NYSE: ABVT)

  • TransUnion Corp. — US$3 billion sale of TransUnion Corp. by Madison Dearborn Partners and certain Pritzker family business interests to Advent International and GS Capital Partners

  • Walgreen Co. — Acquisition of Crescent Healthcare, Inc., an infusion pharmacy company, from Frontenac Company

  • Host Hotels & Resorts — US$4.1 billion acquisition by Host Hotels & Resorts (a public REIT) of 35 hotels from Starwood Hotels & Resorts, including through the merger of Starwood's former paired-share REIT

  • Navistar, Inc. — Negotiation of a joint venture with Caterpillar, Inc., for the development and sale of medium and heavy duty trucks outside North America and a strategic alliance for the manufacture of Caterpillar-branded vocational trucks in North America

  • IDEX Corporation — Acquisitions by IDEX Corporation of Nova Technologies Corporation, a provider of metering technology and flow monitoring services, and Microfluidics International Corporation (OTC: MFLU), a provider of laboratory and commercial equipment used in the production of micro and nano scale materials for the pharmaceutical and chemical markets

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.